Paradigm Biopharmaceuticals (ASX:PAR) – Webinar Presentation

Paul Rennie – Founder and Managing Director – Paradigm Biopharmaceuticals Limited (ASX:PAR) is a global biopharmaceutical company. Its current focus is a drug for the treatment of osteoarthritis.